Prothena Corporation | Harnessing the Power of the immune system to fight progressive disease
Prothena (Nasdaq:PRTA) is a clinical stage biotechnology company focused on the discovery and development of novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding or cell adhesion.
